Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 10:53 AM UTC
| NCT Number | NCT07100106 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 285 participants |
| Active Locations | 32 sites in the US |
| Sponsor | Genentech, Inc. |
| Last Updated on CT.gov | October 6, 2026 (1 week ago) |
As of October 13, 2026: Clinical trial NCT07100106 is currently recruiting participants. This phase1 study for breast cancer is actively seeking new participants at 32 locations across the United States. The study is sponsored by Genentech, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07100106 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 32 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07100106 was last updated 1 week ago (October 6, 2026). HelloStudys verifies this status automatically.